CompletedNot Applicable

Portal Vein Occlusion is a Valuable Predictor for Postoperative Nausea and Vomiting

China380 participantsStarted 2023-06-15

Plain-language summary

Postoperative nausea and vomiting (PONV) is one of the most common and distressing postoperative complications. PONV risk assessment is recommanded to determine the number of medications or strategies for prophylaxis. Many well-known risk factors have been determined. However, no study has explored liver surgery-specific risk factors. This study aims to identify whether there was an association between portal vein occlusion and PONV among patients after liver surgery. Patients diagnosed with liver cancer and undergoing hepatectomy will be prospectively consecutively recruited. All enrolled patients receive PONV assessments within the first 24 postoperative hours. Logistic regression models will be used to investigate the effects of portal vein occlusion and the other variables on the occurrence of PONV in both univariate and multivariate analyses

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * older than 18 years, planned admissions and elective surgery, and staying at least 24 hours in the surgical unit Exclusion Criteria: * patients with cognitive impairment and patients who have nausea and vomiting related to other existing diseases, such as gastroesophageal reflux disease.

What they're measuring

Postoperative nausea and vomiting

Timeframe: up to 24 hours

Trial details

NCT IDNCT05894408

SponsorShanghai Zhongshan Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-08-01

View on ClinicalTrials.gov More Postoperative Nausea and Vomiting trials